| 2026-08-21 | Presentation | 4DMT Corporate Presentation – August 2026 |
| 2026-08-14 | Press release | Press release |
| 2026-08-14 | Press release | 4DMT Announces New Employment Inducement Grants |
| 2026-08-13 | Press release | Press release |
| 2026-08-13 | Press release | 4DMT Reports Second Quarter 2026 Financial Results, Operational Highlights and Expected Upcoming Milestones |
| 2026-07-18 | Press release | Press release |
| 2026-07-18 | Press release | 4DMT Announces Positive 2-Year Data from PRISM Phase 2b Clinical Trial in a Broad Wet AMD Population |
| 2026-07-17 | Presentation | 4DMT Corporate Presentation – July 2026 |
| 2026-07-17 | Press release | Press release |
| 2026-07-17 | Press release | 4DMT Announces New Employment Inducement Grants |
| 2026-06-30 | Press release | Press release |
| 2026-06-30 | Press release | 4DMT Announces Presentation at 44th Annual Scientific Meeting of the American Society of Retina Specialists |
| 2026-06-29 | Press release | Press release |
| 2026-06-29 | Press release | Press release |
| 2026-06-29 | Press release | 4DMT Secures Strategic Credit Facility for up to $200 Million from Hercules Capital |
| 2026-06-29 | Press release | 4DMT Completes Enrollment for 4FRONT-2 Global Phase 3 Clinical Trial of 4D-150 in Wet AMD |
| 2026-06-12 | Press release | Press release |
| 2026-06-12 | Press release | 4DMT Announces New Employment Inducement Grants |
| 2026-05-27 | Press release | 4DMT to Participate in Upcoming Investor Conferences |
| 2026-05-15 | Press release | Press release |
| 2026-05-15 | Press release | 4DMT Announces New Employment Inducement Grants |
| 2026-05-07 | Press release | Press release |
| 2026-05-07 | Press release | 4DMT Reports First Quarter 2026 Financial Results, Operational Highlights and Expected Upcoming Milestones |
| 2026-05-04 | Press release | Press release |
| 2026-05-04 | Press release | 4DMT to Participate in Upcoming Investor Conferences |
| 2026-04-17 | Press release | Press release |
| 2026-04-17 | Press release | 4DMT Announces New Employment Inducement Grants |
| 2026-03-18 | Press release | Press release |
| 2026-03-18 | Press release | 4DMT Reports Full Year 2025 Financial Results, Operational Highlights and Expected Upcoming Milestones |
| 2026-03-16 | Press release | 4DMT to Participate in Upcoming Investor Meetings |
| 2026-02-19 | Press release | 4DMT to Participate in Upcoming Investor Conferences |
| 2026-02-13 | Press release | Press release |
| 2026-02-13 | Press release | 4DMT Announces New Employment Inducement Grants |
| 2026-02-09 | Press release | Press release |
| 2026-02-09 | Press release | 4DMT Completes Enrollment for 4FRONT-1 Phase 3 Clinical Trial of 4D-150 in Wet AMD |
| 2026-01-16 | Press release | Press release |
| 2026-01-16 | Press release | 4DMT Announces New Employment Inducement Grants |
| 2026-01-14 | Presentation | J.P. Morgan 2026 Presentation |
| 2026-01-07 | Press release | Press release |
| 2026-01-07 | Press release | 4DMT Provides Company Update and Anticipated Development Milestones for 2026 |